Diammonium Glycyrrhizinate for Injection
Function and Efficacy
This product has strong anti-inflammatory, liver cell membrane protection and liver function improvement effects. Pharmacological experiments have shown that oral administration of this product to mice can reduce the increase of serum alanine aminotransferase and aspartate aminotransferase caused by carbon tetrachloride, thioacetamide and D-galactosamine. It can also significantly reduce the morphological damage of D-galactosamine to the liver and improve the chronic damage of immune factors to the liver morphology.
Ingredients
The main ingredient of this product is diammonium glycyrrhizinate. Its chemical name is: 20β-carboxyl-11-oxo-n-oleanol-12-ene-3β-yl-2-O-β-D-glucopyranosiduronic acid-a-D-glucopyranosiduronic acid diammonium salt.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Diammonium glycyrrhizinateIngredients |
It has strong anti-inflammatory, liver cell membrane protection and liver function improvement effects. It can reduce the increase of serum alanine aminotransferase and aspartate aminotransferase caused by carbon tetrachloride, thioacetamide and D-galactosamine, significantly reduce the morphological damage of D-galactosamine to the liver and improve the chronic damage of immune factors to the liver morphology. More |
79165-06-3 | 35 |
Appearance
This product is white or off-white lump or powder.
Indication
This product is suitable for the treatment of chronic persistent hepatitis and chronic active hepatitis accompanied by elevated alanine aminotransferase.
Usage and Dosage
Intravenous drip, 150 mg at a time, dissolved and diluted with 250 ml of 10% glucose injection, then slowly dripped, once a day.
Adverse Reactions
1. Digestive system: poor appetite, nausea, vomiting, and abdominal distension may occur. 2. Cardiovascular system: common headaches, dizziness, chest tightness, palpitations, and increased blood pressure. 3. Others: itchy skin, urticaria, dry mouth, and edema. The above symptoms are generally mild and do not affect treatment.
Precautions
It is contraindicated in patients with severe hypokalemia, hypernatremia, hypertension, heart failure, and renal failure.
Drug Interactions
When used in combination with diuretics such as uric acid, furosemide, ethiazide, trichloromethiazide, etc., the diuretic effect can enhance the potassium excretion effect of diammonium glycyrrhizinate contained in this product, resulting in a decrease in serum potassium values. Special attention should be paid to the determination of serum potassium values.
Storage
Keep in a light-proof and airtight container.
Packaging Specification
0.15g
Manufacturer
Reyoung Pharmaceutical Co., Ltd.
-
Founded in:
1998-03-20 -
Address:
No. 1, Ruiyang Road, Yiyuan County, Shandong Province -
Tax NO.:
913703001686121827 -
Registered Funds:
366.74 million yuan -
Website:
-
Email: